Cockcroft D W, Hurst T S, Marciniuk D D, Cotton D J, Laframboise K F, Nagpal A K, Skomro R P
Department of Medicine, Division of Respiratory Medicine, Royal University Hospital, University of Saskatchewan, Saskatoon, Canada.
Chest. 2000 Nov;118(5):1378-81. doi: 10.1378/chest.118.5.1378.
Methacholine-induced bronchoconstriction is associated with significant hypoxemia, which can be assessed noninvasively by transcutaneous oxygen tension and pulse oximetry.
To assess the value of the monitoring of finger pulse oximetry during routine methacholine challenges in a clinical pulmonary function laboratory with regard to both safety and the possibility that a significant fall in oxygen saturation as measured by pulse oximetry (SpO(2)) might be a useful surrogate for determining the response to methacholine.
Two hundred consecutive patients undergoing diagnostic methacholine challenges in the pulmonary function laboratory of a tertiary-care, university-based referral hospital were studied. Methacholine challenges were performed by the standardized 2-min tidal breathing technique, and the DeltaFEV(1) was calculated from the lowest postsaline solution inhalation to the lowest postmethacholine inhalation value. SpO(2) was measured immediately prior to each spirogram, and the DeltaSpO(2) was measured from the lowest postsaline solution inhalation value to the lowest postmethacholine inhalation value. We examined the data for safety (ie, any SpO(2) value < 90). Based on previous reports, we used a DeltaSpO(2) of > or = 3 as significant and looked at the sensitivity, specificity, and positive and negative predictive values for DeltaSpO(2) > or = 3 vis-à-vis a fall in FEV(1) of > or = 15%.
There were 119 nonresponders (DeltaFEV(1), < 15%) and 81 responders. The baseline FEV(1) percent predicted was slightly but significantly lower in the responders (responders [+/- SD], 91.6 +/- 15%; nonresponders, 96.4 +/- 14%; p < 0.05). DeltaSpO(2) was 3.1 +/- 1.6 in the responders and 1.6 +/- 1.8 in the nonresponders (p < 0. 001). There was a single recording in one patient of SpO(2) < 90 (88). A DeltaSpO(2) > or = 3 had a sensitivity of 68%, a specificity of 73%, a positive predictive value of 63%, and negative predictive value of 77% for a fall in FEV(1) > or = 15%.
Pulse oximetry is not routinely useful for safety monitoring during methacholine challenge. DeltaSpO(2) is not helpful in predicting a positive spirometric response to methacholine. However, the negative predictive value is adequate to allow the DeltaSpO(2) to be used as an adjunct in assessing a negative result of a methacholine test in patients who have difficulty performing spirometry.
乙酰甲胆碱诱发的支气管收缩与显著的低氧血症相关,可通过经皮氧分压和脉搏血氧饱和度进行无创评估。
在临床肺功能实验室中,评估常规乙酰甲胆碱激发试验期间手指脉搏血氧饱和度监测对于安全性的价值,以及脉搏血氧饱和度(SpO₂)显著下降作为判断对乙酰甲胆碱反应的有用替代指标的可能性。
对一家三级医疗、大学附属转诊医院肺功能实验室中连续200例接受诊断性乙酰甲胆碱激发试验的患者进行研究。乙酰甲胆碱激发试验采用标准化的2分钟潮气呼吸技术,计算从吸入盐水溶液后最低值到吸入乙酰甲胆碱后最低值的FEV₁变化量(ΔFEV₁)。在每次肺量图检查前即刻测量SpO₂,计算从吸入盐水溶液后最低值到吸入乙酰甲胆碱后最低值的SpO₂变化量(ΔSpO₂)。我们检查数据的安全性(即任何SpO₂值<90)。根据先前的报告,我们将ΔSpO₂≥3视为显著变化,观察ΔSpO₂≥3相对于FEV₁下降≥15%的敏感性、特异性、阳性预测值和阴性预测值。
有119例无反应者(ΔFEV₁<15%)和81例反应者。反应者的预计基线FEV₁百分比略低但有显著差异(反应者[±标准差],91.6±15%;无反应者,96.4±14%;p<0.05)。反应者的ΔSpO₂为3.1±1.6,无反应者为1.6±1.8(p<0.001)。有1例患者的SpO₂记录值<90(88)。对于FEV₁下降≥15%,ΔSpO₂≥3的敏感性为68%,特异性为73%,阳性预测值为63%,阴性预测值为77%。
脉搏血氧饱和度在乙酰甲胆碱激发试验期间对安全性监测并非常规有用。ΔSpO₂无助于预测乙酰甲胆碱激发试验的阳性肺量计反应。然而,阴性预测值足以使ΔSpO₂在评估肺量计检查困难患者的乙酰甲胆碱试验阴性结果时用作辅助指标。